Get started
Author

Harumi Kakuda

Observed names: H Kakuda, HARUMI KAKUDA
ORCID: 0009-0001-3264-894X
Observed ORCID: 0009-0001-3264-894X
OpenAlex ID: A5059767943
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
2009 · Hiroyuki Fujisaki, Harumi Kakuda, et al. · Cancer Research · 618
PDF
ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
2016 · Shinsuke Hirabayashi, Kentaro Ohki, et al. · Haematologica · 248
PDF
Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
1997 · X T Kong, K Ida, et al. · Blood · 138
Replicative potential of human natural killer cells
2009 · Hiroyuki Fujisaki, Harumi Kakuda, et al. · British Journal of Haematology · 106
PDF
Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal
2007 · Virna Marin, Harumi Kakuda, et al. · Experimental Hematology · 49
PDF
Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan
2014 · Miharu Yabe, Yoshitoshi Ohtsuka, et al. · International Journal of Hematology · 43
Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus
1997 · Tatsuroh Joh, Kazuhito Yamamoto, et al. · Oncogene · 39
Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK
1991 · Akira Fuse, Harumi Kakuda, et al. · British Journal of Haematology · 35
Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation
2019 · Nao Yoshida, Hirotoshi Sakaguchi, et al. · Transplantation and Cellular Therapy · 32
PDF
HIV Infection of Megakaryocytic Cell Lines
2000 · Takeyuki Sato, Hiromasa Sekine, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 31
Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond–Blackfan anemia
2020 · Shun Koyamaishi, Takuya Kamio, et al. · Bone Marrow Transplantation · 23
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study
2020 · Hiroshi Moritake, Shiro Tanaka, et al. · Pediatric Blood & Cancer · 22
PDF
Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases
2018 · Daisuke Tomizawa, Masanori Yoshida, et al. · Bone Marrow Transplantation · 22
A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells
1996 · HARUMI KAKUDA, TAKEYUKI SATO, et al. · British Journal of Haematology · 22
BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
2022 · Ko Kudo, Tsutomu Toki, et al. · Haematologica · 14
PDF
Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial
2019 · Nobuyuki Hyakuna, Yoshiko Hashii, et al. · Pediatric Blood & Cancer · 14
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
2021 · Masanori Yoshida, Kazuhiko Nakabayashi, et al. · Blood Advances · 11
Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan
2019 · Takako Miyamura, Kazuko Kudo, et al. · Leukemia Research · 10
Establishment of a new human megakaryoblastic cell line, CMY, with chromosome 17p abnormalities.
1998 · N Miura, T Sato, et al. · International Journal of Molecular Medicine · 10
Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11
2023 · Kazuo Sakashita, Nao Yoshida, et al. · Transplantation and Cellular Therapy · 9
Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma
2014 · Tomoro Hishiki, Hiroshi Horie, et al. · Pediatric Surgery International · 9
Expression of Multidrug Resistant Gene (mdr-1/P-glycoprotein) in a Megakaryoblastic Cell Line, CMK, and its Enhancement During Megakaryocytic Differentiation
1995 · Takeyuki Sato, Setsuo Ota, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia
2021 · Yuko Honda, Hideki Muramatsu, et al. · International Journal of Hematology · 7
The effect of graft‐versus‐host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults
2019 · Tetsuo Mitsui, Naoto Fujita, et al. · Pediatric Blood & Cancer · 7
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors
2019 · Rie Shirayama, Hideyuki Takedani, et al. · Blood Coagulation & Fibrinolysis · 7
Works count: 50
Citation count: 1,561
H-index: 14
I10-index: 19
Year
Topic
Type